Intra-arterial thrombolysis

American Journal of Neuroradiology

Volumn 22, Issue 8 SUPPL., 2001, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; RECOMBINANT PROTEIN; SARUPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; STANDARD; TIME; TREATMENT OUTCOME;

CEREBROVASCULAR ACCIDENT; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INFUSIONS, INTRA-ARTERIAL; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035462185     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thrombocmbolic disease. AJNR Am J Neuroradiol 1983:4:401-404
2. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thrombocmbolic occlusion of the middle cerebral artery. Stroke 1988;19:802-812
3. del Zoppo G, Ferbert A, Otis S, et al. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 1988;19:307-313
4. Gönner F, Remonda L, Maule H, et al. Local intra-arterial thrombolysis in acute ischémie stroke. Stroke 1998;29: 1894-1900
5. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intraarterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 1993:35:159-162
6. Freitag HJ, Becker VU, Thie A, et al. Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings. Neuroradiology 1996; 38:181-185
7. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817-1822
8. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischémie stroke by initial SPECT. Stroke 1994:25:298-303
9. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolie stroke: intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 1995;36: 246-253
10. Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 1995:16:1977-1986
11. Lanzieri CF, Tarr RW, Landis D, et al. Cost-effectiveness of emergency intraarterial intracerebral thrombolysis: a pilot study. AJNR Am J Neuroradiol 1995:16:1987-1993
12. Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996;27:875-881
13. Bendszus M, Urbach H, Ries F, Solymosi L. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 1998:40:54-58
14. Picard L, Bracard S, Maffei L, et al. Selective intra-arterial thrombolysis for embolie complications of cerebral endovascular therapy. Intervent Neuroradiol 1996:2:263-269
15. Casto L, Caverni L, Camerlingo M, et al. Intra-arterial thrombolysis in acute ischaemic stroke: experience with superselective catheter embedded in the clot. J Neural Neurosurg Psychiatry 1996:60:667-670
16. Nesbit GM, Clark WM, O'Neill OR, Barnwell SL. Intracranial intraarterial thrombolysis facilitated by microcathctcr navigation through an occluded cervical internal carotid artery. 7 Neurosurg 1996;84:387-392
17. Theron J, Coskun O, Huet H, Oliveira G, Toulas P, Payella G. Local intraarterial thrombolysis in the carotid territory. Intervent Neuroradiol 1996;2:111-126
18. Yokogami K, Nakano S, Ohta H, Goya T, Wakisaka S. Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion: value of pre- and post-therapeutic computed tomographic findings and angiographie occlusive site. Neurosurgery 1996:39:1102-1107
19. Barr JD, Mathis JM, Wildehain SL, Wechsler L, Jungreis CA, Horton JA. Acute stroke intervention with intraarterial urokinase infusion. J Vase Interv Radial 1994:5:705-713
20. Suarez J, Sunshine J, Tarr R, et al. Predictors of clinical improvement, angiographie recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischémie stroke. Stroke 1999:30:2094-2100
21. Furlan A, Higashida R, Weschler L, et al. Intra-arterial prourokinase for acute ischémie stroke: The PROACT II Study: a randomized controlled trial. JAMA 1999;282:2003-2011
22. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogcn activator for acute ischémie stroke. N Engl J Med 1995:333:1581-1587
23. Cooperative Study between the ASNR, ASITN, and SCVIR. Quality improvement guidelines for adult diagnostic neuroangiography. AJNR Am J Neuroradiol 2000;21:146-150
24. Higashida RT, Hopkins LN, Berenstein A, Halbach W, Kerber C. Program requirements for residency/fellowship education in neuroendovascular surgery/interventional neuroradiology: a special report on graduate medical education. AJNR Am J Neurorarf/o/2000;21:1 153-1159
25. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988;19:547-554
26. Howard G, Toole JF, Becker C, et al. Changes in survival following stroke in five North Carolina counties observed during two different periods. Stroke 1989:20:345-350
27. Ricci S, Celani MG, Guercini G, et al. First-year results of a community-based study of stroke incidence in Umbria, Italy. Stroke 1989;20:853-857
28. Friday G, Lai SM, Alter M, et al. Stroke in the Lehigh Valley: racial/ethnic differences. Neurology 1989;39:1165-1168
29. Kojima S, Omura T, Wakamatsu W, et al. Prognosis and disability of stroke patients after 5 years in Akita, Japan. Stroke 1990;21:72-77
30. Martinez-Vila E, Guillen F, Villanueva JA, et al. Placebo-controlled trial of nimodipine in the treatment of acute ischémie cerebral infarction. Stroke 1990:21:1023-1028
31. Sacco RL, Hauser WA, Mohr JP, Foulkes MA. One-year outcome after cerebral infarction in whites, blacks, and Hispanics. Stroke 1991;22:305-311
32. Candelise L, Pinardi G, Morabito A, and the Italian Acute Stroke Study Group. Mortality in acute stroke with atrial fibrillation. Stroke 1991:22:169-174
33. Brainin M, Czvitkovits, Seiser A, Pauley E. Stroke subtype is an age-independent predictor of early and late stroke mortality: the Klosterneuburg Stroke Data Bank. J Neural 1991;vol: 238-113
34. Monaco P, Pastore L, Cottone S, Conti, Belinvia S. Effect of early treatment with GM1 on neurological impairment during ischémie stroke. J Neural 1991;vol:238-120
35. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991:337:1521-1526
36. D'Alessandro G, Di Giovanni M, Roveyaz L, et al. Incidence and prognosis of stroke in the Valle d'Aosta, Italy: first-year results of a community-based study. Stroke 1992:23:1712-1715
37. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993;24:796-800
38. Censor! B, Camerlingo M, Casto L, et al. Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset. Stroke 1993:24:532-535
39. Sard C, Tuomilehto J, Sivenius J, et al. Stroke mortality and case-fatality rates in three geographic areas of Finland from 1983 to 1986. Stroke 1993:24:1140-1147
40. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for treatment of acute hemispheric stroke: The European Cooperative Acute Stroke Study. JAMA 1995;274:1017-1025
41. Saito I, Segawa H, Shiokawa Y, Taniguchi M, Tsutsumi K. Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome. Stroke 1987; 18: 863-868
42. Moscow NP, Newton TH. Angiographie implications in diagnosis and prognosis of basilar artery occlusion. Am J Roentgenol Radium Ther Nucl Med 1973;119:597-604
43. Thompson JR, Simmons CR, Hasso AN, Hinshaw DB Occlusion of the intradural vertcbasilar artery. Neuroradiology 1978; 14:219-229
44. Kubik CS, Adams RD. Occlusion of the basilar artery: clinical and pathological study. Brain 1946;69:73-121
45. Tomsick T, Barsan W, Brott T, et al. Prognostic value of the hypcrdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996; 17:79-85
46. Wolpert SM, Bruckmann H, Greenlee R, et al. Ncuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 1993;14:3-13
47. Lewandowski C, Frankel M, Tomsick T, et al. Combined intravenous and intra-arterial r-Tl'A versus intra-arterial therapy of acute Ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605
48. Ernst RT, Pancioli A, Tomsick TA, et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischémie stroke. Stroke 2000;31:2552-2557
49. Smalling R, Fuentes F, Matthews M, et al. Sustained improvement in left ventricular function and mortality by intracoronary streptokinase administration during evolving myocardial infarction. Circulation 1983;68:131-138
50. Khaja F, Wallon J, Brymer J, et al. Intracoronary fibrinolytic therapy in acute myocardial infarction: report of a prospective randomized trial. N Engl J Med 1983:308:1305-1311
51. Rogers WJ, Mantle JA, Hood \VP Jr, et al. Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction. Circulation 1983;68:1051-1061
52. Tennant SN, Dixon J, Venable TC, et al. Intracoronary thrombolvsis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase. Circulation 1984;69:756-760
53. Kennedy J, Ritchie J, Davis K, Stadius M, Maynard C, Fritz J. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: a 12-month follow-up report. N Engl J Med 1985;312:1073-1078
54. Kambara H, Kawai C, Kajiwara N, et al. Randomized, doubleblinded multicenter study: comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction. Circulation 1988;78:899-905
55. Natarajan D, Rai VN, Jain A, Roy T, Sharma PK, Nigam PD. Intracoronary versus intravenous streptokinase in acute myocardial infarction. Int J Cardiol 1985;19:181-189
56. Emergency interventional stroke therapy: a statement from the American Society of Neuroradiology and the Society of Cardiovascular and Interventional Radiolog}'. Am J Neuroradiol AJNR 200\;22:54
57. Executive Committee of the ASITN. Intraarterial thrombolysis: ready for prime time? Am J Neuroradiol AJNR 2001;22:55-58